Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate

被引:190
作者
Boyer, JL
Mohanram, A
Camaioni, E
Jacobson, KA
Harden, TK
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] NIDDK, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA
关键词
P2Y(1) antagonist; P2Y(1) receptor; inositol lipid signalling; turkey erythrocytes; phospholipase C;
D O I
10.1038/sj.bjp.0701837
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antagonist activity of N-6-methyl 2'-deoxyadenosine 3',5'-bisphosphate (N6MABP) has been examined at the phospholipase C-coupled P2Y(1) receptor of turkey erythrocyte membranes. N6MABP antagonized 2MeSATP-stimulated inositol phosphate hydrolysis with a potency approximately 20 fold greater than the previously studied parent molecule, adenosine 3',5'-bisphosphate. The P2Y(1) receptor antagonism observed with N6MABP was competitive as revealed by Schild analysis (pK(B) = 6.99 +/- 0.13). Whereas N6MABP was an antagonist at the human P2Y(1) receptor, no antagonist effect of N6MABP was observed at the human P2Y(2), human P2Y(4) or rat P2Y(6) receptors.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 12 条
[1]  
Boyer JL, 1996, DRUG DEVELOP RES, V39, P253, DOI 10.1002/(sici)1098-2299(199611/12)39:3/4<253::aid-ddr4>3.0.co
[2]  
2-q
[3]   DIFFERENTIAL-EFFECTS OF P-2-PURINOCEPTOR ANTAGONISTS ON PHOSPHOLIPASE C-COUPLED AND ADENYLYL CYCLASE-COUPLED P-2Y-PURINOCEPTORS [J].
BOYER, JL ;
ZOHN, IE ;
JACOBSON, KA ;
HARDEN, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) :614-620
[4]  
Boyer JL, 1996, MOL PHARMACOL, V50, P1323
[5]   Molecular cloning and expression of an avian G protein-coupled P2Y receptor [J].
Boyer, JL ;
Waldo, GL ;
Harden, TK .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :928-934
[6]  
BULTMANN R, 1994, N-S ARCH PHARMACOL, V349, P74
[7]   Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors [J].
Camaioni, E ;
Boyer, JL ;
Mohanram, A ;
Harden, TK ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :183-190
[8]   PPADS and suramin as antagonists at cloned P-2Y- and P-2U-purinoceptors [J].
Charlton, SJ ;
Brown, CA ;
Weisman, GA ;
Turner, JT ;
Erb, L ;
Boarder, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (03) :704-710
[9]  
HARDEN TK, 1995, ANNU REV PHARMACOL, V35, P541, DOI 10.1146/annurev.pa.35.040195.002545
[10]   PHARMACOLOGICAL PROFILE OF THE NOVEL P-2T-PURINOCEPTOR ANTAGONIST, FPL-67085 IN-VITRO AND IN THE ANESTHETIZED RAT IN-VIVO [J].
HUMPHRIES, RG ;
TOMLINSON, W ;
CLEGG, JA ;
INGALL, AH ;
KINDON, ND ;
LEFF, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1110-1116